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 Abstract: 
In their study, McKinney et al. showed the high potential of artificial intelligence for breast               
cancer screening. However, the lack of detailed methods and computer code undermines its             
scientific value. We identify obstacles hindering transparent and reproducible AI research as            
faced by ​McKinney et al ​and provide solutions with implications for the broader field. 
 
Main Text: 
The evaluation of deep learning for the detection of breast cancer from mammograms by              
McKinney and colleagues​1 showed promising improvements in screening performance, while          
highlighting challenges around the reproducibility and transparency of ​artificial intelligence (​AI)           
research. ​They assert that their system improves the speed and robustness of breast cancer              
screening, generalizes to populations beyond those used for training, and outperforms           
radiologists in specific settings. Upon successful prospective validation, this new system holds            
great potential for streamlining clinical workflows, reducing false positives, and improving patient            
outcomes. However, the absence of sufficiently documented methods and computer code           
underlying the study effectively undermines its scientific value. This shortcoming limits the            
evidence required for others to prospectively validate and clinically implement such           
technologies. Here, we identify obstacles hindering transparent and reproducible AI research as            
faced by McKinney et al. and provide potential solutions with implications for the broader field. 
 
Scientific progress depends upon the ability of independent researchers to (1) scrutinize the             
results of a research study, (2) reproduce the study’s main results using its materials, and (3)                
build upon them in future studies​2​. Publication of insufficiently documented research violates the             
core principles underlying scientific discovery​3,4​. The authors state ​“​The code used for training             
the models has a large number of dependencies on internal tooling, infrastructure and             
hardware, and its release is therefore not feasible”​. ​Computational reproducibility is           
indispensable for robust AI applications​5,6 more complex methods demand greater          
transparency​7​. In the absence of code, reproducibility falls back on replicating methods from             
textual description. Although, the authors claim that ​“all experiments and implementation details            
are described in sufficient detail in the Supplementary Methods section to support replication             
with non-proprietary libraries”​, key details about their analysis are lacking. Even with sufficient             
description, reproducing complex computational pipelines based purely on text is a subjective            
and challenging task​8,9​. 
 
More specifically, the authors’ description of the model development as well as data processing              
and training pipelines lacks critical details. The definition of multiple hyperparameters for the             
model’s architecture (composed of three networks referred to as the Breast, Lesion, and Case              
models) is missing (Table 1). The authors did not disclose the parameters used for data               
augmentation; the transformations used are stochastic and can significantly affect model           
performance​10​. Details of the training pipeline were also missing. For instance, they state that              
the mini-batches were sampled to contain an equal proportion of negative and positive             
examples, potentially leading to multiple instances of the same patients in a given epoch. Deep               
learning optimization algorithms such as stochastic gradient descent typically operate under the            
 assumption that a given sample is provided to the model exactly once per epoch. The lack of                 
detail regarding the per-batch balancing of classes prevents replicating the training pipeline. 
 
There exist numerous frameworks and platforms to make artificial intelligence research more            
transparent and reproducible (Table 2). For the sharing of code, these include Bitbucket,             
GitHub, and GitLab among others. The multiple software dependencies of large-scale machine            
learning applications require appropriate control of software environment, which can be           
achieved through package managers including Conda, as well as container and virtualization            
systems, including Code Ocean, Gigantum and Colaboratory. If virtualization of the Mckinney et             
al. internal tooling proved to be difficult, they could have released the computer code and               
documentation. The authors could also have created toy examples to show how new data must               
be processed to generate predictions. As for the trained model, many platforms allow sharing of               
deep learning models, including TensorFlow Hub, ModelHub.ai, ModelDepot, and Model Zoo           
with support for multiple frameworks such as PyTorch, Caffe, and TensorFlow. Since the             
authors created their model with the publicly available TensorFlow library, sharing of the model              
should be trivial. In addition to improving accessibility and transparency, such tools can             
significantly accelerate model development, validation, and transition into production and clinical           
implementation. 
 
Another crucial aspect of ensuring reproducibility lies in access to the data the models were               
derived from. In their study, McKinney et al. used two large datasets under license, properly               
disclosing this limitation in their publication. Sharing of patient health information is highly             
regulated due to privacy concerns. Despite these challenges, sharing of raw data has become              
more common in biomedical literature, increasing from under 1% in the early 2000s to 20%               
today​11​. However, if the data cannot be shared, the model predictions and data labels              
themselves should be released, allowing further statistical analyses.  
 
Although sharing of code and data is widely seen as a crucial part of scientific research, the                 
adoption varies across fields. In fields such as genomics, complex computational pipelines and             
sensitive datasets have been shared for decades​12​. Guidelines related to genomic data are             
clear, detailed, and most importantly, enforced. It is generally accepted that all code and data               
are released alongside a publication. In other fields of medicine and science as a whole, this is                 
much less common, and data and code are rarely made available. For scientific efforts where a                
clinical application is envisioned and human lives would be at stake, we argue that the bar of                 
transparency should be set even higher. If data cannot be shared with the entire scientific               
community, because of licensing or other insurmountable issues, at a minimum a mechanism             
should be set so that some highly-trained, independent investigators can access the data and              
verify the analyses. This would allow a truly adequate peer-review of the study and its evidence                
before moving into clinical implementation. 
 
Many egregious failures of science were due to lack of public access to code and data used in                  
the discovery process​13,14​. These unfortunate lessons should not be lost on either journal editors              
or its readers. Journals have an obligation to hold authors to the standards of reproducibility that                
 benefit not only other researchers, but also the creators of a given method. Making one’s               
methods reproducible may surface biases or shortcomings to authors before publication​15​.           
Preventing external validation of a model will likely reduce its impact and could lead to               
unintended consequences​15​. The failure of McKinney et al. to share key materials and             
information transforms their work from a scientific publication open to verification into a             
promotion of a closed technology. 
 
We have high hopes for the utility of AI methods in medicine. Ensuring that these methods meet                 
their potential, however, requires that these studies be reproducible. Unfortunately, the           
biomedical literature is littered with studies that have failed the test of reproducibility, and many               
of these can be tied to methodologies and experimental practices that could not be investigated               
due to failure to fully disclose software and data. This is even more important for applications                
intended for use in the diagnosis or treatment of human disease. 
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 Table 1: Essential hyperparameters for reproducing the study for each of the three             
models (Lesion, Breast, and Case), including those missing from the description in            
Mckinney et al. 
 
 Lesion Breast Case 
Learning rate Missing 0.0001 Missing 
Learning rate 
schedule 
Missing Stated Missing 
Optimizer Stochastic gradient 
descent with 
momentum 
Adam Missing 
Momentum Missing Not applicable Not applicable 
Batch size 4 Unclear 2 
Epochs Missing 120,000 Missing 
 
 
  
 Table 2: Frameworks and platforms to share code, software dependencies and deep 
learning models to make artificial intelligence research more transparent and 
reproducible. 
 
Resource  URL 
Code 
BitBucket  https://bitbucket.org 
GitHub  https://github.com 
GitLab  https://about.gitlab.com 
Software dependencies 
Conda  https://conda.io 
Code Ocean  https://codeocean.com 
Gigantum  https://gigantum.com 
Colaboratory  https://colab.research.google.com 
Deep learning models 
TensorFlow Hub  https://www.tensorflow.org/hub 
ModelHub  http://modelhub.ai 
ModelDepot  https://modeldepot.io 
Model Zoo  https://modelzoo.co 
Deep learning frameworks 
TensorFlow  https://www.tensorflow.org/ 
Caffe  https://caffe.berkeleyvision.org/ 
PyTorch  https://pytorch.org/ 
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